Purchases and Sales Made in Q3 2022 in Endra Life Sciences Inc. (NDRA)
This table provides information about the institutional ownership of Endra Life Sciences Inc. (NDRA) during Q3 2022. The information is specifically focused on institutions that hold shares of ENDRA Life Sciences Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
76KNew |
$17.5K - $24.2M
|
76K
$425K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
14K+ 1.65% |
$3.22K - $4.47M
|
865K
$4.83M
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
30+ 2.06% |
$6.9 - $9.57K
|
1.49K
$8.32K
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-12.7K- 33.13% |
$2.92K - $4.05M
|
25.6K
$143K
|
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-174K- 14.88% |
$40.1K - $55.6M
|
997K
$5.57M
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-282K- 49.92% |
$64.8K - $89.8M
|
282K
$1.58M
|